DDAVP: Review of indications for its use in the treatment of factor VIII deficiency and report of a case
- 30 September 1983
- journal article
- case report
- Published by Elsevier in Oral Surgery, Oral Medicine, Oral Pathology
- Vol. 56 (3) , 246-251
- https://doi.org/10.1016/0030-4220(83)90004-x
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Response of Factor VIII/von Willebrand Factor to DDAVP in Healthy Subjects and Patients with Haemophilia A and von Willebrand's DiseaseBritish Journal of Haematology, 1981
- Specificity in the Factor VIII Response to Vasopressin Infusion in ManBritish Journal of Haematology, 1979
- D.D.A.V.P. IN HÆMOPHILIAThe Lancet, 1977
- D.D.A.V.P. IN HÆMOPHILIAThe Lancet, 1977
- 1-DEAMINO-8-D-ARGININE VASOPRESSIN: A NEW PHARMACOLOGICAL APPROACH TO THE MANAGEMENT OF HAEMOPHILIA AND VON WILLEBRAND'S DISEASEThe Lancet, 1977
- Mechanism of Plasminogen Activator and Factor VIII Increase after Vasoactive DrugsBritish Journal of Haematology, 1975
- A NEW VASOPRESSIN ANALOGUE AND FIBRINOLYSISThe Lancet, 1973
- Factor VIII on the Vascular Intima: Possible Importance in Haemostasis and ThrombosisNature New Biology, 1973
- EFFECTS OF DDAVP, A SYNTHETIC ANALOGUE OF VASOPRESSIN, IN PATIENTS WITH CRANIAL DIABETES INSIPIDUSActa Medica Scandinavica, 1972
- EFFECT OF A SYNTHETIC ANALOGUE OF VASOPRESSIN IN ANIMALS AND IN PATIENTS WITH DIABETES INSIPIDUSThe Lancet, 1968